Guangzhou Baiyunshan Pharmaceutical Statistics Share Statistics Guangzhou Baiyunshan Pharmaceutical has 2.47B
shares outstanding. The number of shares has increased by 4.4%
in one year.
Shares Outstanding 2.47B Shares Change (YoY) 4.4% Shares Change (QoQ) -0.61% Owned by Institutions (%) n/a Shares Floating 2.47B Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 16K, so 0% of the outstanding
shares have been sold short.
Short Interest 16K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 999.99
Valuation Ratios The PE ratio is 12.05 and the forward
PE ratio is 8.36.
Guangzhou Baiyunshan Pharmaceutical's PEG ratio is
-0.4.
PE Ratio 12.05 Forward PE 8.36 PS Ratio 0.46 Forward PS 0.5 PB Ratio 0.95 P/FCF Ratio 14.77 PEG Ratio -0.4
Financial Ratio History Enterprise Valuation Guangzhou Baiyunshan Pharmaceutical has an Enterprise Value (EV) of 28.28B.
EV / Sales 0.38 EV / EBITDA 5.77 EV / EBIT 8.21 EV / FCF 12.22
Financial Position The company has a current ratio of 1.48,
with a Debt / Equity ratio of 0.34.
Current Ratio 1.48 Quick Ratio 1.16 Debt / Equity 0.34 Debt / EBITDA 2.52 Debt / FCF 5.35 Interest Coverage 8.6
Financial Efficiency Return on Equity is 7.9% and Return on Invested Capital is 5.76%.
Return on Equity 7.9% Return on Assets 3.47% Return on Invested Capital 5.76% Revenue Per Employee $2.67M Profits Per Employee $100.77K Employee Count 28,138 Asset Turnover 0.92 Inventory Turnover 4.88
Taxes Income Tax 606.85M Effective Tax Rate 16.82%
Stock Price Statistics The stock price has increased by -18.75% in the
last 52 weeks. The beta is 0.56, so Guangzhou Baiyunshan Pharmaceutical's
price volatility has been higher than the market average.
Beta 0.56 52-Week Price Change -18.75% 50-Day Moving Average 2.32 200-Day Moving Average 2.53 Relative Strength Index (RSI) 48.86 Average Volume (20 Days) 1,272
Income Statement In the last 12 months, Guangzhou Baiyunshan Pharmaceutical had revenue of 74.99B
and earned 2.84B
in profits. Earnings per share was 1.74.
Revenue 74.99B Gross Profit 12.52B Operating Income 3.6B Net Income 2.84B EBITDA 4.9B EBIT 4.03B Earnings Per Share (EPS) 1.74
Full Income Statement Balance Sheet The company has 18.27B in cash and 12.37B in
debt, giving a net cash position of 5.9B.
Cash & Cash Equivalents 18.27B Total Debt 12.37B Net Cash 5.9B Retained Earnings 21.82B Total Assets 82.42B Working Capital 20.38B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 3.44B
and capital expenditures -1.13B, giving a free cash flow of 2.31B.
Operating Cash Flow 3.44B Capital Expenditures -1.13B Free Cash Flow 2.31B FCF Per Share 1.42
Full Cash Flow Statement Margins Gross margin is 16.7%, with operating and profit margins of 4.8% and 3.78%.
Gross Margin 16.7% Operating Margin 4.8% Pretax Margin 4.81% Profit Margin 3.78% EBITDA Margin 6.54% EBIT Margin 4.8% FCF Margin 3.09%
Dividends & Yields GZPHF pays an annual dividend of $0.17,
which amounts to a dividend yield of 7.16%.
Dividend Per Share $0.17 Dividend Yield 7.16% Dividend Growth (YoY) -47.25% Payout Ratio 70.36% Earnings Yield 8.3% FCF Yield 6.77%
Dividend Details Analyst Forecast Currently there are no analyst rating for GZPHF.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $8.7 Lynch Upside 271.79% Graham Number 29.44 Graham Upside 1158.12%
Stock Splits The last stock split was on Jan 28, 2014. It was a
forward
split with a ratio of 10031:10000.
Last Split Date Jan 28, 2014 Split Type forward Split Ratio 10031:10000
Scores Altman Z-Score 1.85 Piotroski F-Score 5
